Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Claudication Clinical Trials

A listing of Claudication medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (38) clinical trials

For more information please visit: http://clinicaltrials.gov/ct2/show/NCT00401518?term=The+Investigational+Plan+for+the+Evaluation+of+the+ACADIA+Facet+Replacement&rank=1

Phase N/A

Claudication, or calf pain, is often a symptom related to a more serious disorder called peripheral vascular disease. PVD refers to blood vessel disease outside the heart and brain. Most commonly it is caused by a narrowing of the vessels that carry blood to muscles in the legs and arms, ...

Phase N/A

Leg Thermotherapy for Intermittent Claudication

Peripheral arterial disease is characterized by atherosclerotic obstruction of the arteries in the lower extremities and affects approximately 10% of individuals older than 65 years. The most common clinical presentation of peripheral arterial disease is intermittent claudication, defined as leg pain caused by insufficient blood flow during walking. Individuals with ...

Phase N/A

Study to Evaluate the Lower Extremity Intervention With Integrated Embolic Protection Using the Vanguard IEP System

The ENTRAP Study is a prospective, multi-center, non-randomized, single-arm, study with follow-up to 30 days to determine the acute safety, acute device performance and clinical performance of the Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection. The Vanguard IEP Peripheral Balloon Angioplasty System with Integrated Embolic Protection is ...

Phase N/A

Lower Extremity Peripheral Arterial Disease and Exercise Ischemia

Primary Outcome Measure : Coefficient of determination between the recovery duration and subsequent walking performance, obtained from individual regression analyses. Secondary outcome measures : Coefficient of determination determined from different curves fitting. Coefficient of correlation between the level of ischemia during recovery and exercise ischemia and pain occurrence during subsequent ...

Phase N/A

Pedicle Osteotomy for Stenosis Trial

LSS is a narrowing of the spinal canal and/or the intervertebral foramina by bony spurs or soft tissues that decrease space for the neural elements resulting in compression of the nerve roots or spinal cord in the lumbar region of the spine. LSS can cause low back pain, weakness, numbness, ...

Phase N/A

Paclitaxel Eluting Stent in Long SFA Obstruction: A Prospective Randomized Comparison With Bypass Surgery

BACKGROUND Chronic lower limb ischemia due to atherosclerosis causes significant morbidity especially in elderly: the prevalence of asymptomatic obstructive peripheral atherosclerosis among 40-74 old is 4-22%. The prevalence of its milder symptomatic manifestation, intermittent claudication among 40 years old men is about 1% and among 70 years old it is ...

Phase

Does Neuromuscular Electrical Stimulation Improve the Absolute Walking Distance in Patients With Intermittent Claudication Compared to Best Available Treatment?

Intermittent claudication (IC) is caused by a blockage in the artery of the leg, causing muscle pain. Although some evidence of the efficacy of neuromuscular electrical stimulation (NMES) in the management of patients with IC exists, further high quality research is required. This proposed study is vital to identify the ...

Phase N/A

RECCORD (Recording Courses of Vascular Diseases) Registry

For details see NM Malyar et al., Rationale and design of the RECording COurses of vasculaR Diseases registry (RECCORD registry). Vasa. https://doi.org/10.1024/0301-1526/a000631

Phase N/A

Exercise Rehabilitation in Veterans With PAD

Peripheral artery disease (PAD) and its associated declines in physical function impair quality of life (QOL) in nearly 20% of older Veterans and result in substantial VA health care costs. Revascularization addresses the anatomical pathology, but does not restore mobility function and QOL. Optimal therapy may require post-revascularization rehabilitation to ...

Phase N/A